CD 1530 Size:Contact [email protected] for quotation InChi: InChI=1S/C27H21ClF5N7O3S/c1-38-20(11-22(36-38)27(31

InChi: InChI=1S/C27H21ClF5N7O3S/c1-38-20(11-22(36-38)27(31

Smiles: CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O

5S)-5-[({4'-carbamimidoyl-[1

5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62

CD 1530 Size:Contact [email protected] for quotation InChi: InChI=1S/C27H21ClF5N7O3S/c1-38-20(11-22(36-38)27(31Target: RAR, RAR and RAR Ki: 150, 1500, and 2750 nM CD1530 is a potent and selective RAR receptor agonist with Ki values of 150, 1500 and 2750 nM for RAR, RAR and RAR receptors, respectively . In addition, CD1530 shows moderate RAR selectivity in the transcriptional assay with AC50 value of 1. 8 nM. RAR is present in the majority of tissues while the distribution of RAR and is more selective . RAR mediated retinoic acid (RA) induced growth arrest and